0
Article Tier 2 Sign in to save

Nanoplastics and Neurodegeneration: A Roadmap From Mechanism to Causation

AI summary Read the abstract

Researchers synthesize emerging evidence that nanoplastics can cross the blood-brain barrier, accelerate amyloid aggregation, impair microglial clearance, and drive neuroinflammation via the gut-liver-brain axis — mechanisms tied to Alzheimer's and Parkinson's disease — while mapping the scientific gaps in exposure data and causality that must be closed before definitive conclusions can be drawn.

Nanoplastics are ubiquitous by-products of global plastic production and have emerged as a potentially consequential yet insufficiently defined threat to health. Recent studies have revealed that these synthetic particulates can cross the blood-brain barrier, accelerate amyloid aggregation, impair microglial clearance, hijack the gut-liver-brain axis, and drive neuroinflammation-mechanisms central to neurodegeneration in Alzheimer's and Parkinson's disease. In addition, anionic nanoplastics can induce vascular endothelial leakiness, thereby harboring a paracellular route for their systemic and cerebral access. Yet causality remains unproven in implicating nanoplastics for neurodegeneration in the absence of standardized human exposure data, mechanistic specificity, and epidemiological evidence, especially considering the supra-environmental doses employed. Here, we synthesize current knowledge, examine barriers to causal understanding, and propose a roadmap to advance this emerging scientific frontier of great public concern and inform future strategies for sustainable materials innovation.

More Papers Like This

Article Tier 2

Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities

AI summary Read the abstract

Researchers reviewed emerging evidence that micro- and nanoplastics may contribute to neurodegeneration by promoting neuroinflammation, oxidative stress, blood-brain barrier disruption, and direct interactions with aggregation-prone proteins like amyloid-β and α-synuclein, proposing that pre-existing neurological disease may increase susceptibility to particulate accumulation in brain tissue.

Article Tier 2

From the Environment to Molecular Interactions of Nanoplastics: Unraveling the Neurotoxic Impacts and the Implications in Neurodegenerative Processes

AI summary Read the abstract

This review examines how nanoplastics can cross the blood-brain barrier and potentially contribute to brain damage and neurodegenerative diseases like Alzheimer's and Parkinson's. Nanoplastics have been found in food, water, and air, and once they reach the brain they can trigger inflammation, oxidative stress, and protein misfolding. The review calls for more realistic lab studies and better detection methods to understand the true scope of nanoplastic effects on brain health.

Article Tier 2

Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities

AI summary Read the abstract

Researchers review how microplastics and nanoplastics may reach the brain via inhalation and systemic routes, proposing that chronic neuroinflammation, oxidative stress, and direct interactions with proteins like amyloid-β and α-synuclein could link particle exposure to Alzheimer's, Parkinson's, and other neurodegenerative conditions.

Article Tier 2

Micro- and Nanoplastics in the Human Brain: Mechanistic Plausibility, Translational Challenges, and Links to Neurological Disease Trends.

AI summary Read the abstract

Researchers synthesized evidence that micro- and nanoplastics can accumulate in human brain tissue via multiple barrier-crossing routes and, once there, disrupt synaptic function, mitochondrial homeostasis, and neuroinflammatory pathways relevant to Alzheimer's, Parkinson's, stroke, and mood disorders — while emphasizing that longitudinal epidemiological evidence linking plastic exposure to neurological disease remains limited.

Article Tier 2

The role of microplastics exposure in Alzheimer’s and Parkinson’s disease

AI summary Read the abstract

Researchers reviewed the mechanistic links between microplastic and nanoplastic exposure and the two most common neurodegenerative diseases — Alzheimer's and Parkinson's — finding evidence that oxidative stress, neuroinflammation, blood-brain barrier disruption, and protein aggregation are key pathways connecting plastic pollution to neurodegeneration.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper